Close
4

Seqens Seqens

X

Company profile for Ionctura

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Ionctura’s pipeline contains an exquisitely selective PI3Kδ small molecule inhibitor which has just entered a phase I clinical trial in solid tumours, a second generation selective ATX small molecule inhibitor that is in IND enabling studies and an early preclinical phase anti-CD73 antibody program. Developing molecules that individually harness the combined effect of immune-mediated and direct anti-tumour activity.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Ionctura
Switzerland Flag
Country
Country
Switzerland
Address
Address
Campus Biotech Innovation Park, Bâtiment F2, Avenue Sécheron 15, Geneva
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY